Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cancer Vaccines01:30

Cancer Vaccines

877
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
877

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-Cost Versatile Microfluidic Platform for Bioorthogonal Click-Mediated Nanoassembly of Hybrid Nanosystems.

Nanomaterials (Basel, Switzerland)·2025
Same author

Silicasomes in Oncology: From Conventional Chemotherapy to Combined Immunotherapy.

Molecules (Basel, Switzerland)·2025
Same author

Liposomal-Based Nanoarchitectonics as Bispecific T Cell Engagers in Neuroblastoma Therapy.

ACS applied materials & interfaces·2025
Same author

Dual-pore protocells with multitasking capacities for simultaneous delivery of therapeutic enzymes and drugs in macrophage depletion therapy.

Biomaterials science·2024
Same author

Nanomaterials and Nanostructures Hand-In-Hand with Biology.

Nanomaterials (Basel, Switzerland)·2022
Same author

Strategies for the Biofunctionalization of Straining Flow Spinning Regenerated <i>Bombyx mori</i> Fibers.

Molecules (Basel, Switzerland)·2022

Related Experiment Video

Updated: Dec 25, 2025

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

7.8K

Tumor Targeted Nanocarriers for Immunotherapy.

Alejandro Baeza1,1

  • 1Dpto. Materiales y Producción Aeroespacial, ETSI Aeronáutica y del Espacio, Universidad Politécnica de Madrid, 28040 Madrid, Spain.

Molecules (Basel, Switzerland)
|April 1, 2020
PubMed
Summary

Nanoparticles offer targeted cancer therapy, but face challenges like poor tumor penetration. Exploiting immune cells

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Immunology

Background:

  • Passive accumulation of nanoparticles in tumors spurred nanocarrier development for targeted drug delivery.
  • Existing nanomedicines face challenges including poor tumor penetration and rapid immune clearance, limiting clinical success.

Purpose of the Study:

  • To review recent advances in nanocarriers designed to interact with both immune and tumor cells.
  • To explore strategies for orchestrating an effective anti-tumor response by leveraging nanocarrier-immune cell interactions.

Main Methods:

  • Review of current literature on nanocarrier design and their application in cancer therapy.
  • Analysis of strategies employing nanocarriers for immune cell targeting and modulation.
Keywords:
cancer therapydrug deliveryimmunotherapynanomedicine

More Related Videos

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
09:23

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

1.3K
Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

11.3K

Related Experiment Videos

Last Updated: Dec 25, 2025

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

7.8K
Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
09:23

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

1.3K
Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

11.3K

Main Results:

  • Nanoparticles can be engineered with stimuli-responsive properties, targeting abilities, and imaging capabilities.
  • Immune cell clearance of nanoparticles, previously a barrier, is being repurposed for targeted delivery of immunoregulatory agents.

Conclusions:

  • Combining nanotechnology with immunotherapy presents a promising approach for developing potent anti-cancer treatments.
  • Future nanomedicines leveraging immune cell interactions offer potential for safer and more effective cancer therapies.